Skip to content
Research Article Open access CC BY 4.0

Plasma Fibrinogen in Chronic Obstructive Pulmonary Disease – A Cross Sectional Study Conducted in a Tertiary Care Hospital in Puducherry, India

Bency K. Thomas, S. Yuvarajan

Journal of Advances in Medicine and Medical Research · pp. 1–8 · Published 18 Mar 2016

10.9734/BJMMR/2016/24549

Abstract

Background: Chronic Obstructive Pulmonary Disease (COPD) is a systemic disorder rather than a respiratory disease. A significant complication that COPD can lead to a hypercoagulable state, which can lead to life-threatening diseases like Ischemic heart disease, deep vein thrombosis and Pulmonary embolism. Therefore, Fibrinogen is a useful biomarker to predict the risk of such hyper-coagulable state in COPD patients. Objectives: The study was aimed to measure the fibrinogen levels in COPD patients, to correlate the fibrinogen levels with severity of airway obstruction based on spirometry and also to compare the fibrinogen levels in COPD exacerbation patients with stable COPD individuals and healthy non-smokers. Methods: Spirometric measurement and measurement of Plasma Fibrinogen was performed on 60 patients (20 COPD patients with exacerbation; 20 stable COPD patients and 20 healthy non-smokers). Results: Raised plasma fibrinogen levels were observed in COPD patients when compared to healthy non-smokers. There was increase in the fibrinogen levels with severity of air obstruction. Among the COPD patients, raised fibrinogen levels were observed in exacerbation individuals when compared to stable COPD individuals. Conclusion: Plasma fibrinogen is a useful biomarker to monitor the disease severity in addition to the spirometric parameters in COPD patients. It gives a clue to the possibility of developing systemic complication of a hypercoagulable in COPD patients.

COPD plasma fibrinogen exacerbation hypercoagulation biomarker

References (28)

  1. 1 Acute-Phase Proteins and Other Systemic Responses to Inflammation [DOI]
  2. 2 HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY [DOI]
  3. 3 Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis [DOI]
  4. 4 Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction [DOI]
  5. 5 Changes in Forced Expiratory Volume in 1 Second over Time in COPD [DOI]
  6. 6 Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD [DOI]
  7. 7 Extrapulmonary Effects of Chronic Obstructive Pulmonary Disease on Physical Activity [DOI]
  8. 8 Obstructive and restrictive lung disease and markers of inflammation: data from the third national health and nutrition examination [DOI]
  9. 9 Systemic inflammation in chronic obstructive pulmonary disease: a population-based study [DOI]
  10. 10 The natural history of chronic obstructive pulmonary disease [DOI]
  11. 11 Determinants of Systemic Vascular Function in Patients with Stable Chronic Obstructive Pulmonary Disease [DOI]
  12. 12 Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease: Table 1 [DOI]
  13. 13 Physical activity monitoring in COPD: Compliance and associations with clinical characteristics in a multicenter study [DOI]
  14. 14 Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease [DOI]
  15. 15 Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group.
  16. 16 Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease [DOI]
  17. 17 Airway and systemic inflammation and decline in lung function in patients with COPD [DOI]
  18. 18 Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation [DOI]
  19. 19 Clinical, functional and biochemical changes during recovery from COPD exacerbations [DOI]
  20. 20 Markers of early disease and prognosis in COPD [DOI]
  21. 21 The natural history of chronic obstructive pulmonary disease [DOI]
  22. 22 Hypercoagulability State in Patients with Chronic Obstructive Pulmonary Disease [DOI]
  23. 23 Relationship between Plasma Fibrinogen Levels and Pulmonary Function in the Japanese Population: The Takahata Study [DOI]
  24. 24 Three-dimensional structural studies on fragments of fibrinogen and fibrin [DOI]
  25. 25 Megakaryocyte and hepatocyte origins of human fibrinogen biosynthesis exhibit hepatocyte-specific expression of gamma chain-variant polypeptides [DOI]
  26. 26 Etiología y biomarcadores de inflamación sistémica en las exacerbaciones leves a moderadas de la enfermedad pulmonar obstructiva crónica [DOI]
  27. 27 CORRELATION OF CRP AND SERUM FIBRINOGEN LEVELS WITH DISEASE SEVERITY, CLINICAL FACTORS AND PULMONARY FUNCTION TESTS IN COPD PATIENTS
  28. 28 India needs a national COPD prevention and control programme.

Cited by 4

Outcome of short-term systemic steroid therapy in chronic obstructive pulmonary disease patients with acute exacerbation

Ashraf Zin El-Abdeen, Lamiaa H. Shaaban, Shereen Farghaly · Egyptian Journal of Bronchology · 2018

Hypercoagulable State in COPD-A Comprehensive Literature Review

Christos Kyriakopoulos, Athena Gogali, Konstantinos Kostikas · Diagnostics · 2021

Showing 2 of 4 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

7

Page views

0

PDF downloads

0

Outbound clicks

4

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.